The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
THOXINE (Accord Healthcare Pty Ltd)
Product name
THOXINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 (255 working days)
Active ingredients
levothyroxine sodium
Registration type
New generic medicine
Indication
THOXINE is indicated for the management of demonstrated thyroid hormone deficiency.
THOXINE is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.